Compare LIF & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LIF | ALKS |
|---|---|---|
| Founded | 2008 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | N/A | 1991 |
| Metric | LIF | ALKS |
|---|---|---|
| Price | $56.96 | $31.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 13 |
| Target Price | ★ $91.93 | $42.85 |
| AVG Volume (30 Days) | 803.8K | ★ 1.8M |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.44 |
| EPS | 0.12 | ★ 2.02 |
| Revenue | $459,031,000.00 | ★ $1,521,338,000.00 |
| Revenue This Year | $30.95 | N/A |
| Revenue Next Year | $31.65 | $22.50 |
| P/E Ratio | $157.55 | ★ $15.72 |
| Revenue Growth | ★ 33.86 | 1.08 |
| 52 Week Low | $29.62 | $25.17 |
| 52 Week High | $112.54 | $36.45 |
| Indicator | LIF | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 27.37 | 70.93 |
| Support Level | $61.05 | $28.93 |
| Resistance Level | $66.30 | $31.96 |
| Average True Range (ATR) | 2.33 | 0.94 |
| MACD | -0.20 | 0.38 |
| Stochastic Oscillator | 0.79 | 94.17 |
Life360 is the world's largest family focused social network, with nearly 100 million monthly active users. Security-conscious families use the Life360 app to track each other's whereabouts and to track the location of their pets and personal belongings. Life360 also offers a suite of additional security features, such as driver safety monitoring, roadside assistance, and emergency dispatching. In the US, the Life360 app regularly ranks in the top 10 most popular social-networking apps and in the top 25 across all apps in terms of daily active users.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.